Results 81 to 90 of about 47,365 (201)
In complex samples (faeces, soil, food, etc.), Clostridium difficile is often present in the form of dormant spores that cause reduced effectiveness of DNA extraction.
Jana Avberšek +4 more
doaj +1 more source
Review Article: The Impact of the Gut Microbiome on Ulcerative Colitis Pharmacotherapy
The gut microbiome modulates ulcerative colitis pharmacotherapy through microbial drug metabolism, immune regulation and altered drug bioavailability. Microbial composition influences response to aminosalicylates, corticosteroids, immunomodulators, biologics and small molecules, while microbiome‐targeted therapies show emerging promise.
Kate Collins +6 more
wiley +1 more source
Seventy-five meconium samples were examined for the presence of CI. difficile: 3 strains were isola ted. Additionally 45 labora tory animal faeces specimens were tested for the same purpose, a further 2 cases were isolated.
MODABER
doaj +2 more sources
The Issue of Early Diagnosis of Intestinal Complications at Antibiotic Therapy in Children
The objective of the research was to improve the timely diagnosis of intestinal complications of antibiotic therapy, caused by Clostridium difficile infection in children.
O.A. Radutna +3 more
doaj +1 more source
Gut microbiota as a novel therapeutic target for eating disorders and obesity
The graphical abstract highlights the bidirectional interaction between the gut microbiota and central homeostatic and hedonic mechanisms regulating food intake, which contributes to overweight and obesity. It also illustrates emerging microbiota‐based biomarkers and therapeutic strategies (including prebiotics, probiotics, postbiotics, synbiotics and ...
Solveiga Samulėnaitė +5 more
wiley +1 more source
Abstract Background Current treatment options for equine gastric ulcer syndrome (EGUS), such as omeprazole—a proton pump inhibitor (PPI)—have notable limitations, including the need for administration on an empty stomach. Potassium‐competitive acid blockers (P‐CABs), such as vonoprazan, are a newer class of acid suppressants that offer several ...
Camilo J. Morales +4 more
wiley +1 more source
Background Surotomycin, a novel, orally administered, cyclic, lipopeptide antibacterial in development for the treatment of Clostridium difficile-associated diarrhea, has demonstrated minimal intestinal absorption in animal models.
Gurudatt Chandorkar +4 more
doaj +1 more source
Systemic effects of sunlight: 10‐year review of cardiovascular, infection and cancer outcomes
This review highlights the systemic effects of sunlight and ultraviolet radiation. While UV radiation exposure has known cutaneous risks including photoaging and skin cancer, evidence suggests potential associations with reduced all‐cause mortality, improved infectious disease outcomes and reduced blood pressure.
Jasira A. Ziglar +5 more
wiley +1 more source
Background and Aim Clostridium difficile is the main cause of Antibiotic-Associated Diarrhea (AAD) in the hospital setting. Today, the use of probiotics for the prevention and treatment of AAD and colitis is increasing. In this study, we investigated the
Masoomeh Sofian +4 more
doaj
The difficile in Clostridium difficile infection [PDF]
Garabet, Akoghlanian, Seetha, Lakshmi
openaire +2 more sources

